P53mutations in urinary bladder cancer patients from Central Poland
✍ Scribed by Edyta Borkowska; Aleksandra Binka-Kowalska; Maria Constantinou; Agnieszka Nawrocka; Józef Matych; Bogdan Kałuźewski
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 133 KB
- Volume
- 48
- Category
- Article
- ISSN
- 1234-1983
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We investigated if the presence of single nucleotide polymorphisms (SNPs) in the XRCC1, XRCC3, and XPD genes were associated with the type and frequency of p53 mutations in bladder cancer. Using a hospital-based case-control study we have previously reported risks for the XRCC1 codon 194, XRCC1 codo
The cause of Li-Fraumeni syndrome, a rare group syndrome of familial cancers, has recently been identified. Patients with this inherited condition are highly susceptible to specific neoplasms, including early-onset breast cancers. The available evidence links Li-Fraumeni syndrome to inherited mutati
Microsatellite instability (MIN) and loss of heterozygosity (LOH) in bladder cancer have been suggested for diagnosis and follow-up of bladder cancer based on urinary sediments, reflecting tumor alterations. We have examined 6 microsatellites in urine sediments from 11 patients with transitional-cel